Adding TTFields to first-line treatment with temozolomide and radiotherapy improved progression-free survival in patients with glioblastoma.
In its accelerated approval decisions of new cancer drugs, the FDA might be underestimating the willingness of some patients ...
A CXB boost continues to provide an organ preservation benefit at 5 years, though there is some local regrowth after 3 years, ...
Pre-operative fractionated stereotactic radiotherapy (FSRT) may produce better outcomes than post-operative FSRT in cancer patients with brain metastases.
The combination of ACT001 and radiotherapy elicited responses and was considered well tolerated in a phase 2 trial of pediatric patients with newly diagnosed DIPG.
Patients with recurrent glioblastoma may derive a greater benefit from sacituzumab govitecan if they have high TROP2 expression.
The US Food and Drug Administration (FDA) has granted accelerated approval to Ziihera (zanidatamab-hrii) for the treatment of adults with previously treated, unresectable or metastatic HER2-positive ...
Critics say that, if RFK Jr. is made secretary of the HHS, a radical antiestablishment medical movement with roots in past centuries would take power.
A decade ago, an old work injury put Fred Blackman II in the hospital with a slipped spinal disc that threatened to paralyze ...
Interventions to improve health literacy should be further investigated or developed to assist individuals with limited ...
Study authors said toripalimab plus chemotherapy could be a first-line treatment option, but authors of a related commentary ...
More research is needed to investigate the cause of the decline in cutaneous melanoma incidence among young patients, researchers say.